Although this body of evidence suggests that simultaneous TAZ and YAP inhibition might help restrain the growth of human iCCA, previous findings indicate that concomitant loss of the two genes severely impairs liver regeneration and paradoxically drives the development of hepatocellular adenomas [49, 50]. This evidence concerns the gene YAP1 and hepatocellular adenoma.